Tharimmune (THAR) Revenue & Revenue Breakdown
Tharimmune Revenue Highlights
0
Latest Revenue (Q)
$1.50M
Tharimmune Revenue by Period
Tharimmune Revenue by Year
| Date | Revenue | Change |
|---|---|---|
| 2025-12-31 | - | 100.00% |
| 2024-12-31 | - | 100.00% |
| 2023-12-31 | - | 100.00% |
| 2022-12-31 | - | 100.00% |
| 2021-12-31 | - | 100.00% |
| 2020-12-31 | - | 100.00% |
| 2019-12-31 | - | - |
Tharimmune generated - in revenue during NA 2025, up 100.00% compared to the previous quarter, and up NaN% compared to the same period a year ago.
Tharimmune Revenue by Quarter
| Date | Revenue | Change |
|---|---|---|
| 2026-06-30 | $1.50M | 100.00% |
| 2026-03-31 | - | 100.00% |
| 2025-12-31 | - | 100.00% |
| 2025-09-30 | - | 100.00% |
| 2025-06-30 | - | 100.00% |
| 2025-03-31 | - | 100.00% |
| 2024-12-31 | - | 100.00% |
| 2024-09-30 | - | 100.00% |
| 2024-06-30 | - | 100.00% |
| 2024-03-31 | - | 100.00% |
| 2023-12-31 | - | 100.00% |
| 2023-09-30 | - | 100.00% |
| 2023-06-30 | - | 100.00% |
| 2023-03-31 | - | 100.00% |
| 2022-12-31 | - | 100.00% |
| 2022-09-30 | - | 100.00% |
| 2022-06-30 | - | 100.00% |
| 2022-03-31 | - | 100.00% |
| 2021-12-31 | - | 100.00% |
| 2021-09-30 | - | 100.00% |
| 2021-06-30 | - | 100.00% |
| 2021-03-31 | - | 100.00% |
| 2020-12-31 | - | 100.00% |
| 2020-09-30 | - | 100.00% |
| 2020-06-30 | - | 100.00% |
| 2020-03-31 | - | - |
Tharimmune generated $1.50M in revenue during Q2 2026, up 100.00% compared to the previous quarter, and up Infinity% compared to the same period a year ago.
Tharimmune Revenue Breakdown
Tharimmune Revenue Breakdown by Product
Quarterly Revenue by Product
| Product/Service | Jun 26 |
|---|---|
| Other Revenue | $1.30M |
Latest
Tharimmune's latest quarterly revenue breakdown by segment (product or service), as of Jun 26: Other Revenue (100.00%).
Tharimmune Peer Comparison by Revenue
| Ticker | Company | Last Year Revenue | Last Quarter Revenue |
|---|---|---|---|
| MGIH | Millennium Group | $45.60M | $23.81M |
| ANL | Adlai Nortye | $5.00M | $2.50M |
| HYPD | Hyperion DeFi | $57.34K | $302.51K |
| APRE | Aprea Therapeutics | - | - |
| APLM | Apollomics | - | - |
| LIMN | Liminatus Pharma, Inc. Class A | - | - |
| CNTN | Canton Strategic | - | $1.50M |
| THAR | Tharimmune | - | $1.50M |
| PBM | Psyence Biomedical | - | - |
| ELAB | PMGC | - | $1.31M |